A breakthrough in life-saving medical technology has arrived. The U.S. Food and Drug Administration (FDA) has officially ...

Silver Spring, Md Thursday, December 26, 2024, 11:00 Hrs [IST] ...

The single-use product is surgically implanted for arterial replacement and repair after a traumatic injury to the extremity.

The FDA has granted a groundbreaking approval to Humacyte for its off-the-shelf, bioengineered blood vessel implant, designed ...

The U.S. Food and Drug Administration approved Symvess, the first acellular tissue engineered vessel indicated for use in ...

The FDA on Friday approved acellular tissue engineered vessel (Symvess), an off-the-shelf product for treating vascular ...

Aroa Biosurgery is targeting the growing lower-limb surgical salvage market with its Myriad family of products, which have ...

1 Department of Biotherapy, State Key Laboratory of Biotherapy and Cancer Center, West China Hospital, Sichuan University, Chengdu, Sichuan, China 2 Department of Pancreatic Surgery, West China ...

We investigated whether disruption of the blood-brain barrier, generated using circulating small extracellular vesicles (sEVs) from women with preeclampsia or placentae cultured under hypoxic ...

Their findings have been published in the journal Gut. The study highlights the extracellular matrix protein 1 (ECM1) as a central component of potential new therapies aimed at preventing liver ...

Extracellular vesicles (EVs) are a new communication mode between cells ... Hyperglycemia and insulin resistance can cause ferroptosis, ROS and AGE production, vascular lesions, which further ...

involves cancer cells reshaping their cell surfaces to snatch extra nutrients from the jelly-like substance between cells or extracellular matrix. This cellular contortion is a process called ...